Navigating Gastrointestinal Challenges: Insight Into GERD and H. pylori Management

To participate in this activity, please:

Log in Sign Up

Gastroesophageal reflux disease (GERD) and Helicobacter pylori (H. pylori) infection are significant gastrointestinal challenges that impact patient quality of life, requiring proper diagnosis and treatment. In this 60-minute, case-based educational activity, multidisciplinary faculty guide clinicians through contemporary diagnostic techniques and evidence-based treatment strategies for both nonerosive and erosive GERD, as well as H. pylori infection. The primary care-oriented activity includes discussion on the importance of understanding the pathophysiology of these conditions, addressing the risks associated with the long-term use of proton pump inhibitors, and integrating newly approved therapeutic options, all to address unmet needs in current practice.

This content is also availble as a podcast: You may listen here.

Course Credit:

1.00 AAPA Category I CME Credit
1.00 ACPE Contact Hour
1.00 AMA PRA Category 1 CreditTM
1.00 ANCC Contact Hour
1.00 CA-BRN Contact Hour
1.00 Pharmacology Hour

Dates:

Opens: 2025-06-18
Closes: 2026-06-18

Target Audience:

Audience of family physicians, internists, advanced practitioners and pharmacists who have a role in the diagnosis, management, and monitoring of patients with gastroesophageal reflux disease (GERD) or H. pylori infection.

This activity is supported by an educational grant from Phathom Pharmaceuticals, Inc.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 1 hour . Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 hour AAPA Category 1 CME credits. Approval is valid until June 18, 2026. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 ANCC contact hour, including 1 pharmacology hour.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.

Additional Content Planners

Amber Lambert, MSN, FNP-C, DNP (Nurse Reviewer)
No significant relationships to disclose.

Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.

Michael Smith, PharmD, BCPS (Medical Writer)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Jonathon Firnhaber, MD, MAEd, MBA headshot

    Jonathon Firnhaber, MD, MAEd, MBA

    Professor and Interim Chair
    Department of Family Medicine
    Brody School of Medicine
    East Carolina University
    Greenville, North Carolina

  • Joel J. Heidelbaugh, MD headshot

    Joel J. Heidelbaugh, MD

    Professor
    Departments of Family Medicine and Urology
    University of Michigan Medical School
    Ann Arbor, Michigan

  • Philip O. Katz, MD headshot

    Philip O. Katz, MD

    Professor of Medicine
    Director GI Function Laboratories
    Division of Gastroenterology
    Course Director Area of Concentration Program
    Weill Cornell Medicine
    New York, New York

Learning Objectives

  • Describe the natural history and burden of GERD and H. pylori infections
  • Identify appropriate tests to support decision-making in the differential diagnosis of GERD and H. pylori infections.
  • Individualize therapy in patients with non-erosive or erosive GERD who achieve an inadequate response to PPI therapy.
  • Evaluate the latest evidence-based guidelines for the treatment of H. pylori infections, including implementing effective eradication regimens and addressing antibiotic resistance

Faculty Disclosures

Jonathon Firnhaber, MD, MAEd, MBA

No relationships to disclose.

Joel J. Heidelbaugh, MD

No relationships to disclose.

Philip O. Katz, MD

Consultant: Phathom Pharmaceuticals, Sebela Pharmaceuticals Inc.